Reissantia buchananii
Reissantia buchananii · Accepted scientific name
Scientific literature: Very Sparse (1 studies) · ★☆☆☆☆
Reissantia buchananii is a botanical species that has garnered significant attention in pharmacological research due to its diverse therapeutic potential. Scientists are particularly interested in the plant's remarkable antitumor activities, which suggest its utility in cancer treatment studies. The medicinal efficacy of this species is largely attributed to its complex profile of bioactive secondary metabolites. Among these critical compounds are pristimerin and celastrol, both of which are recognized for their potent biological effects. Understanding these chemical constituents provides a foundation for exploring new advancements in natural drug development.
- Synonyms
- Hippocratea Buchananii · Hippocratea Menyharthii
- Common names
- Not available
- Family
- Celastraceae
- Distribution
- Not available
- Plant Parts
- Not available
Classification
Synonyms
Reissantia buchananii is a botanical species that has been subject to various taxonomic classifications over time. In scientific literature, this plant is frequently identified by its synonyms, including Hippocratea buchananii. Furthermore, researchers have also linked the species to the name Hippocratea menyharthii. These overlapping designations highlight the complex historical shifting of its placement within different genera. Understanding these relationships is essential for maintaining accurate botanical records and ensuring clear communication among specialists.
Sources: The World Checklist of Vascular Plants (WCVP)
Taxonomy
Reissantia buchananii is a specialized member of the kingdom Plantae. Within this vast biological realm, the species is classified under the class Equisetopsida. It belongs to the specific order Celastrales, which helps scientists understand its evolutionary history. Furthermore, it is a distinguished representative of the genus Reissantia. This botanical lineage is completed by its placement within the Celastraceae family.
| Rank | Classification |
|---|---|
| Kingdom | Plantae |
| Phylum | Streptophyta |
| Class | Equisetopsida |
| Subclass | Magnoliidae |
| Order | Celastrales |
| Family | Celastraceae |
| Genus | Reissantia |
Sources: The World Checklist of Vascular Plants (WCVP)
Distribution
Geographic Regions
Reissantia buchananii is a notable plant species found across several diverse regions of the African continent. Its natural distribution spans from East Tropical Africa, specifically within Tanzania, to the southern reaches of the continent. In South Tropical Africa, this plant can be found thriving in the landscapes of Malawi and Mozambique. Furthermore, its presence extends into the territories of Zambia and Zimbabwe. This broad range highlights the plant's ability to inhabit various ecological niches throughout these African nations.
Sources: The World Checklist of Vascular Plants (WCVP)
Identification
Morphology
Reissantia buchananii is a distinctive shrub characterized by its obligatory climbing habit. This climbing plant can vary significantly in size depending on its environment. It typically reaches a minimum height of 1.5 meters as it begins its ascent. At its full maturity, the species can achieve a maximum height of 9 meters.
Sources: Global Inventory of Floras and Traits (GIFT)
Biological Activities
Reissantia buchananii has demonstrated significant potential in the field of pharmacology due to its documented antitumor activity. Researchers isolated twenty-one distinct compounds from the plant, including five novel agarofuran sesquiterpenes known as reissantins A-E. Notably, the major terpenoid components identified within the species are celastrol and its derivative, pristimerin. These specific compounds exhibited potent inhibitory effects against nine different cancer cell lines during bioassay testing. The impressive efficacy was highlighted by low ED50 values, suggesting that this plant is a rich source of bioactive agents for cancer research.
Compounds
Reissantia buchananii serves as a significant source of bioactive compounds that demonstrate potent antitumor properties. Through bioassay-directed fractionation, researchers isolated twenty-one distinct compounds from this plant species. Among these findings, the major terpenoid components include the highly active substances celastrol and pristimerin. These specific chemical constituents are found directly within Reissantia buchananii and contribute to its therapeutic potential. Ultimately, the presence of both celastrol and pristimerin allows the plant to show significant activity against various cancer cell lines.